The occurrence of mutant KRAS clones in the blood of RAS wild type colorectal cancer patients - impact of response or failure under anti-EGFR therapy

被引：0
|
作者：
Berger, A. W. [1 ]
Schwerdel, D. [1 ]
Welz, H. [1 ]
Moeller, P. [2 ]
Ettrich, T. J. [1 ]
Seufferlein, T. [1 ]
机构：
[1] Univ Ulm Klinikum, Klin Innere Med 1, Ulm, Germany
[2] Univ Ulm Klinikum, Inst Pathol, Ulm, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0514
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [21] PREDICTING RESPONSE TO ANTI-EGFR THERAPY FOR COLORECTAL CARCINOMA BY KRAS MUTATION TESTING
    Dubus, Pierre
    Berhouet, Sabine
    Carrere, Nathalie
    Merlio, Jean Philippe
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 420 - 421
  • [22] Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
    Rizzo, Sergio
    Bronte, Giuseppe
    Fanale, Daniele
    Corsini, Lidia
    Silvestris, Nicola
    Santini, Daniele
    Gulotta, Gaspare
    Bazan, Viviana
    Gebbia, Nicola
    Fulfaro, Fabio
    Russo, Antonio
    CANCER TREATMENT REVIEWS, 2010, 36 : S56 - S61
  • [23] EGFR gene copy number to predict response to anti-EGFR treatment and survival in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer
    Carpen, Olli
    Algars, Annika
    Sundstrom, Jari
    Kytola, Soili
    Osterlund, Pia
    Lintunen, Minnamaija
    Jokilehto, Terhi
    Kaare, Milja
    Orpana, Arto
    Vainionpaa, Reetta
    Ristimaki, Ari
    Ristamaki, Raija
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Sandra Misale
    Rona Yaeger
    Sebastijan Hobor
    Elisa Scala
    Manickam Janakiraman
    David Liska
    Emanuele Valtorta
    Roberta Schiavo
    Michela Buscarino
    Giulia Siravegna
    Katia Bencardino
    Andrea Cercek
    Chin-Tung Chen
    Silvio Veronese
    Carlo Zanon
    Andrea Sartore-Bianchi
    Marcello Gambacorta
    Margherita Gallicchio
    Efsevia Vakiani
    Valentina Boscaro
    Enzo Medico
    Martin Weiser
    Salvatore Siena
    Federica Di Nicolantonio
    David Solit
    Alberto Bardelli
    Nature, 2012, 486 : 532 - 536
  • [25] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Misale, Sandra
    Yaeger, Rona
    Hobor, Sebastijan
    Scala, Elisa
    Janakiraman, Manickam
    Liska, David
    Valtorta, Emanuele
    Schiavo, Roberta
    Buscarino, Michela
    Siravegna, Giulia
    Bencardino, Katia
    Cercek, Andrea
    Chen, Chin-Tung
    Veronese, Silvio
    Zanon, Carlo
    Sartore-Bianchi, Andrea
    Gambacorta, Marcello
    Gallicchio, Margherita
    Vakiani, Efsevia
    Boscaro, Valentina
    Medico, Enzo
    Weiser, Martin
    Siena, Salvatore
    Di Nicolantonio, Federica
    Solit, David
    Bardelli, Alberto
    NATURE, 2012, 486 (7404) : 532 - U131
  • [26] BENEFIT FROM ANTI-EGFR THERAPY IN KRAS, BRAF, NRAS, PI3KCA "ALL WILD TYPE", EGFR POSITIVE COLORECTAL CANCER PATIENTS.
    De Maglio, Giovanna
    Aprile, Giuseppe
    Foltran, Luisa
    Masiero, Elena
    Lutrino, Stefania
    Cardellino, Giovanni
    Fontanella, Caterina
    Fasola, Gianpiero
    Pizzolitto, Stefano
    ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
  • [27] Response to Anti-EGFR Therapy in Patients with BRAF non-V600-Mutant Metastatic Colorectal Cancer
    Yaeger, Rona
    Kotani, Daisuke
    Mondaca, Sebastian
    Parikh, Aparna R.
    Bando, Hideaki
    Van Seventer, Emily E.
    Taniguchi, Hiroya
    Zhao, HuiYong
    Thant, Claire N.
    de Stanchina, Elisa
    Rosen, Neal
    Corcoran, Ryan B.
    Yoshino, Takayuki
    Yao, Zhan
    Ebi, Hiromichi
    CLINICAL CANCER RESEARCH, 2019, 25 (23) : 7089 - 7097
  • [28] Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer
    Tougeron, David
    Lecomte, Thierry
    Pages, Jean-Christophe
    Collin, Christine
    Villalva, Claire
    Ferru, Aurelie
    Tourani, Jean Marc
    Silvain, Christine
    Levillain, Pierre
    Karayan-Tapon, Lucie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Lievre, Astrid
    Ouine, Berengere
    Canet, Jim
    Cartier, Aurelie
    Amar, Yael
    Cacheux, Wulfran
    Mariani, Odette
    Guimbaud, Rosine
    Selves, Janick
    Lecomte, Thierry
    Guyetant, Serge
    Bieche, Ivan
    Berger, Frederique
    de Koning, Leanne
    BRITISH JOURNAL OF CANCER, 2017, 117 (12) : 1819 - 1827
  • [30] Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
    Astrid Lièvre
    Bérèngere Ouine
    Jim Canet
    Aurélie Cartier
    Yael Amar
    Wulfran Cacheux
    Odette Mariani
    Rosine Guimbaud
    Janick Selves
    Thierry Lecomte
    Serge Guyetant
    Ivan Bieche
    Frédérique Berger
    Leanne de Koning
    British Journal of Cancer, 2017, 117 : 1819 - 1827
12345